Skip to main content

Advertisement

Log in

Contrast-enhanced ultrasonography to detect liver metastases

A prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background/aims

The advent of contrast-enhanced ultrasound (CEUS) has called into question the efficacy of standard ultrasonographic techniques. In this study, we evaluated B-mode and color-duplex imaging and CEUS in the detection of liver metastases, using intraoperative and histological findings as a reference.

Materials and methods

Before laparotomy, 108 patients suspected of having liver metastases were prospectively examined with B-mode and color-duplex imaging, followed by contrast-enhanced ultrasound (2.4 ml SonoVue). Patients with unresectable tumors (n=8) were excluded from the analysis. The sonographic diagnosis in the remaining 100 patients was compared to the intraoperative and histological findings.

Results/findings

CEUS improved the sensitivity for detecting liver lesions from 56.3% (B-mode) to 83.8% (CEUS) (p=0.004). In particular, the contrast agent led to an improvement in ultrasonographic detection in the following cases: nodular metastases smaller than one centimeter; after adjuvant chemotherapy; for tumors near the surface of the liver; and for lesions situated around the ligamentum teres.

Interpretation/conclusions

CEUS provides significant improvement in the detection of liver metastases, and should therefore, be performed routinely in the surveillance of cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Tocchi A, Mazzoni G, Brozzetti S, Miccini M, Cassini D, Bettelli E (2004) Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome. Int J Colorectal Dis 19:580–585

    Article  PubMed  Google Scholar 

  2. Konopke R, Saeger H-D (2003) Lebermetastasen: Diagnostik und Therapie 74:866–886

    CAS  Google Scholar 

  3. Scheele J, Altendorf-Hofmann A, Grube T, Hohenberger W, Stangl R, Schmidt K (2001) Resection of colorectal liver metastases. What prognostic factors determine patient selection? Chirurg 72:547–560

    Article  PubMed  CAS  Google Scholar 

  4. Luque-de Leon E, Tsiotos GG, Balsiger B, Barnwell J, Burgart LJ, Sarr MG (1999) Staging laparoscopy for pancreatic cancer should be used to select the best means of palliation and not only to maximize the resectability rate. J Gastrointest Surg 3:111–117

    Article  PubMed  CAS  Google Scholar 

  5. Sakorafas GH, Tsiotou AG (1999) Surgical palliation of pancreatic cancer. Eur J Surg Oncol 25:556

    Article  PubMed  CAS  Google Scholar 

  6. Adam R (2003) Chemotherapy and surgery. New perspectives on the treatment of unresectable liver metastases. Ann Oncol 14(Suppl 2):ii13–ii16

    Article  PubMed  Google Scholar 

  7. Nakamura S, Suzuki S, Baba S (1997) Resection of liver metastases of colorectal carcinoma. World J Surg 21:741–747

    Article  PubMed  CAS  Google Scholar 

  8. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis consecutive cases. Ann Surg 230:309–318

    Article  PubMed  CAS  Google Scholar 

  9. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77:1254–1262

    Article  PubMed  CAS  Google Scholar 

  10. Bernatik T, Strobel D, Hahn EG, Becker D (2001) Detection of liver metastases: comparison of contrast-enhanced wide-band harmonic imaging with conventional ultrasonography. J Ultrasound Med 20:509–515

    PubMed  CAS  Google Scholar 

  11. Eberhardt S, Choi P, Bach A, Funt S, Felderman H, Hann L (2003) Utility of sonography for small hepatic lesions found on computed tomography in patients with Cancer. J Ultrasound Med 22:335–343

    PubMed  Google Scholar 

  12. Jang HJ, Lim HK, Lee WJ, Kim SH, Kim KA, Kim EY (2000) Ultrasonographic evaluation of focal hepatic lesions: comparison of pulse inversion harmonic, tissue harmonic and conventional imaging techniques. J Ultrasound Med 19:293–299

    PubMed  CAS  Google Scholar 

  13. Fevery J, Baert AL, Marchal GM, Broeckaert L, De Groote J, Vantrappen G (1985) The value of computed tomography, ultrasonography, and peritoneoscopy with biopsy in the detection of liver metastases secondary to gastro-enterological tumors. Acta Gastroenterol Belg 48:105–110

    PubMed  CAS  Google Scholar 

  14. Schreve RH, Terpstra OT, Ausema L, Lameris JS, van Seijen AJ, Jeekel J (1984) Detection of liver metastases. A prospective study comparing liver enzymes, scintigraphy, ultrasonography and computed tomography. Br J Surg 71:947–949

    PubMed  CAS  Google Scholar 

  15. Dietrich Ch, Becker D (2002) Signalverstärkte Farbdopplersonographie des Abdomens. Byk Gulden, Konstanz

  16. Albrecht T (2003) Contrast medium-supported sonography of the liver—a challenge to German radiology. Rofo 175:889–891

    PubMed  CAS  Google Scholar 

  17. Hohmann J, Skrok J, Puls R, Albrecht T (2003) Characterization of fokal liver lesion with contrast-enhanced low MI real time ultrasound and SonoVue. Fortschr Röntgenstr 175:835–843

    Article  CAS  Google Scholar 

  18. von Herbay A, Vogt C, Willers R, Haussinger D (2004) Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 23:1557–1568

    PubMed  Google Scholar 

  19. Youk JH, Kim CS, Lee JM (2003) Contrast-enhanced agent detection imaging. Value in the characterisation of focal hepatic lesions. J Ultrasound Med 22:910–987

    Google Scholar 

  20. Solbiati L, Tonolini M, Cova L, Goldberg N (2001) The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 11(suppl 3):E15–E26

    Article  PubMed  Google Scholar 

  21. Hölscher AH, Stadler J (1989) Intraoperative Sonographie zum Nachweis occulter Lebermetastasen beim kolorektalen Carzinom. Langenbecks Arch Chir 374:363–369

    Article  PubMed  Google Scholar 

  22. Vogl TJ, Schwarz W, Blume S et al (2003) Preoperative evaluation of malignant liver tumours: comparison of unenhanced and SPIO (Revovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol 13:262–272

    PubMed  Google Scholar 

  23. Bokor D, Chambers JB, Rees PJ, Mant TG, Luzzani F, Spinazzi A (2001) Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest Radiol 36:104–109

    Article  PubMed  CAS  Google Scholar 

  24. Morel DR, Schwieger I, Hohn L, Terrettaz J, Llull JB, Cornioley YA, Schneider M (2000) Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 35:80–85

    Article  PubMed  CAS  Google Scholar 

  25. de Groot MC, van Zwieten-Boot BJ, van Grootheest AC (2004) Severe adverse reactions after the use of sulphur hexafluoride (SonoVue) as an ultrasonographic contrast agent. Ned Tijdschr Geneeskd 148:1887–1888

    PubMed  Google Scholar 

  26. Torzilli G (2005) Adverse effects associated with SonoVue use. Expert Opin Drug Saf 4:399–401

    Article  PubMed  CAS  Google Scholar 

  27. Wilson SR, Burns PN, Muradali D, Wilson JALai X (2000) Harmonic hepatic US with microbubbles contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma and metastases. Radiology 215:153–161

    PubMed  CAS  Google Scholar 

  28. Strobel D, Hoefer A, Martus P, Hahn EG, Becker D (2001) Dynamic contrast-enhanced power Doppler sonography improves the differential diagnosis of liver lesions. Int J Colorectal Dis 16:247–256

    Article  PubMed  CAS  Google Scholar 

  29. Basilico R, Blomley MJ, Harvey CJ et al (2002) Which continuous US scanning mode is optimal for the Detection of vascularity in liver lesions when enhanced with the second generation contrast agent. Eur J Radiol 41:184–191

    Article  PubMed  Google Scholar 

  30. Leen E (2001) The role of contrast-enhanced ultrasound in the characterisation of fokal liver lesions. Eur Radiol 11(suppl. 3):E27–E34

    Article  PubMed  Google Scholar 

  31. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG (2000) Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 216:411–417

    PubMed  CAS  Google Scholar 

  32. Albrecht T, Blomley MJ, Burns PN et al (2003) Improved detection of hepatic metastases with pulse-inversio US during the liver-specific phase of SHU 508A: multicenter study. Radiology 227:361–370

    PubMed  Google Scholar 

  33. Bunk A, Stolben E, Konopke R, Nagel M, Saeger H-D (1998) Color Doppler sonography in liver surgery. Status of perioperative monitoring. J Ultrasound Med 19:202–212

    CAS  Google Scholar 

  34. Gross M, Zoller WG (1995) Ultrasound criteria versus histology. Bildgebung 62:25–30

    PubMed  Google Scholar 

  35. Bernatik T, Becker D, Neureiter D et al (2003) Detection of liver metastases—comparison of contrast-enhanced ultrasound using first versus second generation contrast agents. J Ultrasound Med 24:175–179

    CAS  Google Scholar 

  36. Konopke R, Kersting S, Saeger H-D, Bunk A (2005) Detection of liver lesions by contrast-enhanced ultrasound—comparison to intraoperative findings. Ultraschall Med 26:107–113

    Article  PubMed  CAS  Google Scholar 

  37. Schuessler G, Ignee A, Hirche T, Dietrich CF (2003) Improved detection and characterisation of liver tumors with echo-enhanced ultrasound. Z Gastroenterol 41:1167–1176

    Article  PubMed  CAS  Google Scholar 

  38. Lencioni R, Cioni D, Crocetti L et al (2002) Ultrasound imaging of focal liver lesions with a second-generation contrast Agent. Acad Radiol 9(suppl 2):371–374

    Article  Google Scholar 

  39. Harvey CJ, Blomley MJ, Eckersley RJ, Heckemann RA, Butler-Barnes J, Cosgrove DO (2000) Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. Lancet 355:807–808

    Article  PubMed  CAS  Google Scholar 

  40. Dalla Palma L, Bertolotto M, Quaia E, Locatelli M (1999) Detection of liver metastases with pulse inversion harmonic imaging: preliminary results. Eur Radiol 9(suppl 3):382–387

    Article  Google Scholar 

  41. Kockerling F, Schug-Pass C, Weskott HP, Tatchen R (2000) Malignant hepatobiliary tumors. Surgical requirement concerning preoperative diagnosis. Zentralbl Chir 125:616–623

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Konopke.

Additional information

Dr. Konopke and Dr. Kersting contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konopke, R., Kersting, S., Bergert, H. et al. Contrast-enhanced ultrasonography to detect liver metastases. Int J Colorectal Dis 22, 201–207 (2007). https://doi.org/10.1007/s00384-006-0134-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-006-0134-5

Keywords

Navigation